To examine the growth inhibitory effects of
Phyllanthus emblica (P. emblica ) and Terminalia bellerica
(T. bellerica ) extracts on human hepatocellular carcinoma
(HepG2), and lung carcinoma (A549) cells and their
synergistic effect with doxorubicin or cisplatin